DePuy Synthes Launches Nailing System Aimed at Improving Treatment of Femoral Shaft Fractures

Published by Meba on

New system is designed to enhance anatomic fit and offer surgeons more options to improve patient outcomes.

DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, announced the U.S. launch of its Femoral Recon Nail System, a nailing system that provides new options for the surgical treatment of a wide variety of long thigh bone fractures. This new system builds on the company’s comprehensive trauma portfolio of solutions designed to improve outcomes for patients with hip and femur fractures.

The overall annual number of femoral shaft fractures in the U.S. is estimated at approximately 90,000.1 The DePuy Synthes Femoral Recon Nail System is a fixation system that utilizes an intramedullary nail to repair femoral shaft fractures. The system provides a surgeon with a state of the art nailing system that is designed to provide stability and allow patients to move soon after surgery while optimizing patient outcomes.

The Femoral Recon Nail System offers surgical entry point and locking options to accommodate varying preferences, and enables surgeons to treat a broad range of complex fractures. The system also features radiolucent insertion handles that aim to reduce surgical complexity, facilitate intraoperative and X-ray visualization, and assist with guide wire placement.

“I believe the DePuy Synthes Femoral Recon Nail System offers the most streamlined insertion instruments on the market,” said Pete Nowotarski M.D., professor Orthopaedic Surgery, University of Tennessee College of Medicine, Chattanooga & Orthopaedic Trauma Director, Erlanger Health Systems, and consultant to DePuy Synthes Trauma. “This system, coupled with the most advanced design features in both the piriformis fossa and greater trochanter entry points, offers greater versatility in treating complex femur fractures.”

In addition, the DePuy Synthes system is also designed to address a potential operative complication called distal cortical impingement, which is often the result of the curve of the patient’s femoral anatomy being greater than the curve of the nail.2 The Femoral Recon Nail System addresses this issue as it is specifically designed to enhance anatomical fit3 by reducing the rate of nail curvature to more closely match the patient’s anatomy that may also further improve the patient’s experience.

“DePuy Synthes has a long history of innovation in the hip and femur fracture repair market with a comprehensive portfolio of implants that address a variety of patient needs,” said I.V. Hall, global platform leader, DePuy Synthes Trauma. “This launch allows DePuy Synthes to offer the most comprehensive, best-in-class portfolio for hip and femur fractures as we continue to advance the standard of care for patients and improve the surgeon experience.”

The Johnson & Johnson Medical Devices Companies’ purpose is to reach more patients and restore more lives. Having advanced patient care for more than a century, these companies represent an unparalleled breadth of products, services, programs and research and development capabilities in surgical technology, orthopaedics, and interventional solutions with an offering directed at delivering clinical and economic value to health care systems worldwide.

DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, provides one of the most comprehensive orthopedics portfolios in the world. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, craniomaxillofacial, spinal surgery and sports medicine, are designed to advance patient care while delivering clinical and economic value to healthcare systems worldwide.

Source: www.odtmag.com


0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

en_GBEnglish
en_GBEnglish ro_RORomanian